The Therapeutic Goods Administration (TGA) was established to safeguard and enhance the health of the Australian community through effective and timely regulation of therapeutic goods. The organisation works with industry, consumers and health professionals and its international counterparts in order to effectively regulate increasingly complex medicines and medical devices resulting from rapid scientific and medical developments. As a division of the Department of Health, the TGA enforces the Therapeutic Goods Act (Cht) 1989 and subordinate regulations.
Most dental products supplied in Australia are categorised as a "medical device" for regulatory purposes and the manufacture, export and supply within Australia of dental product is regulated by the TGA.
The TGA ensures that the Australian community has access, within a reasonable time, to therapeutic advances. The regulatory framework is based on a risk management approach designed to ensure public health and safety. The TGA also regulates manufacturers of therapeutic goods to ensure they meet acceptable standards of manufacturing quality. It has a team of inspectors that audit manufacturing facilities around the world to ensure that products supplied in Australia are of high quality.
As the peak business organisation representing manufacturers and suppliers of quality dental products, the Australian Dental Industry Association (ADIA) affords members the opportunity to engage with the TGA on the development of regulatory standards for the approval of dental product. At the request of the Australian Government, ADIA represents the dental industry on the: